December 15th, 2015

Stock Update (NASDAQ:BIIB): Biogen to Present at the 34th Annual J.P. Morgan Healthcare Conference

[Business Wire] – Biogen Inc. announced today that it will present at the 34th Annual J.P. Morgan Healthcare Conference. The webcast will be live on Monday, January 11, 2016 at 3:30 p.m. Read more on this. Biogen Inc. (BIIB) , valued at $66.33B, opened this morning at $294.84. Looking at the stock, its one day range is $294.63 to $298.04 with a trailing 52-week range being $254.00 to $480.18. Priced at 17.96x this year’s forecasted earnings, BIIB shares are relatively expensive compared to the industry’s -2.16x forward p/e ratio. In a review of the consensus earnings estimate this quarter, 19 sell-side analysts are looking at $4.05 per share, which would be $0.04 worse than the year-ago quarter and a $0.01 sequential increase. What we find to be interesting is that the full-year EPS estimate of $16.55 is a $2.72 improvement when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $2.70 Billion. If realized, that would be a 2.27% increase over the year-ago quarter. Recently, Raymond James Initiated BIIB at Strong Buy (Sep 1, 2015). Previously, H.C. Wainwright Initiated BIIB at to Buy. The average price target for BIIB shares by the analysts covering it is $364.36, which is 23.58% above where the stock opened. See more in (NASDAQ:BIIB) Similar Articles: Market Update: Biogen Idec Inc (NASDAQ:BIIB) – SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws — BIIB Stock Update: Biogen Idec Inc (NASDAQ:BIIB) – BIIB INVESTORS: The Law Offices of Howard G. Smith Announces An Investigation On Behalf Of Biogen, Inc. Investors Market Update: Biogen Idec Inc (NASDAQ:BIIB) – SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen, Inc. – BIIB
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.